ArticleJMIR medical informatics2026
Automated Renal Tumor Segmentation in Computed Tomography Images Using a Global Attention-Based DeepLabV3+ Model: Algorithm Development and Validation.
Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The rising global incidence of renal tumors necessitates precise diagnostic interventions. Accurate segmentation of computed tomography (CT) scans is essential for nephron-sparing surgery and radiotherapy. However, conventional manual delineation is labor-intensive and prone to significant interobserver variability due to tumor morphological heterogeneity. There is an urgent clinical demand for robust, automated segmentation solutions. Objective: This study aims to develop and validate GAM-DeepLabV3+, an automated framework designed to address boundary ambiguity and high false-positive rates in complex renal imaging scenarios. Methods: We propose an optimized encoder-decoder architecture specifically tailored for renal mass detection. The framework incorporates three key innovations: (1) a lightweight MobileNetV2 backbone to minimize computational overhead for clinical deployment; (2) an Atrous Spatial Pyramid Pooling (ASPP) module to capture multiscale contextual information; and (3) a Global Attention Mechanism (GAM) in the decoder to enhance channel-spatial interactions, thereby refining boundary delineation by suppressing background noise. The model was rigorously evaluated on a private clinical dataset (n=218) and the KiTS19 benchmark (n=210). Results: GAM-DeepLabV3+ consistently outperformed state-of-the-art baselines. On the private dataset, the model achieved a mean Dice similarity coefficient (DSC) of 0.939 (SD 0.008), significantly surpassing feature pyramid network (FPN; mean 0.893, SD 0.008; Conclusions: The GAM-DeepLabV3+ framework provides an accurate, efficient, and fully automated solution for renal tumor segmentation. By overcoming boundary ambiguity and optimizing feature fusion, this approach shows potential as a decision-support aid, pending future validation with 3D reconstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.